Related Experiment Videos
An analysis of human sperm chromosome breakpoints
A M Estop1, C Márquez, S Munné
1Department of Medical Genetics, Western Pennsylvania Hospital, University of Pittsburgh.
American Journal of Human Genetics
|February 1, 1995
Summary
Sperm chromosome analysis revealed a median of 9.3% structural aberrations. These sperm breakpoints correlate with de novo rearrangements found in prenatal diagnosis, suggesting a link between sperm DNA damage and genetic disorders.
Area of Science:
- Human Genetics
- Reproductive Biology
- Cytogenetics
Background:
- Sperm chromosome structural aberrations can impact reproductive outcomes.
- Understanding the nature and frequency of these aberrations is crucial for genetic counseling and fertility treatments.
Purpose of the Study:
- To investigate the characteristics of sperm chromosome structural aberrations in donors with normal or balanced karyotypes.
- To explore the relationship between sperm breakpoints and de novo chromosomal rearrangements.
Main Methods:
- Karyotyping of 2,389 sperm cells from 19 donors after in vitro penetration of hamster eggs.
- Analysis of sperm structural aberrations, including chromosome-type and chromatid-type aberrations.
- Comparison of aberration frequencies between two study centers and correlation with literature data.
Main Results:
- A median of 9.3% sperm structural aberrations was observed.
- Nonrejoined and rejoined chromosome-type aberrations showed similar frequencies between centers.
- Chromatid-type aberrations were significantly more frequent in one center (P = .037).
- Chromosome 4 exhibited fewer breakpoints than expected (P < .001).
- A significant positive correlation was found between sperm breakpoints and sites of de novo rearrangements (P = .0001).
Conclusions:
- Sperm chromosome analysis provides insights into structural aberrations.
- The correlation suggests that sperm DNA damage sites may predispose to de novo rearrangements observed in prenatal diagnoses.
- Findings have implications for understanding male infertility and genetic risk assessment.